1. Home
  2. VIR vs BSIG Comparison

VIR vs BSIG Comparison

Compare VIR & BSIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • BSIG
  • Stock Information
  • Founded
  • VIR 2016
  • BSIG 1980
  • Country
  • VIR United States
  • BSIG United States
  • Employees
  • VIR N/A
  • BSIG N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • BSIG Investment Managers
  • Sector
  • VIR Health Care
  • BSIG Finance
  • Exchange
  • VIR Nasdaq
  • BSIG Nasdaq
  • Market Cap
  • VIR 1.0B
  • BSIG 1.0B
  • IPO Year
  • VIR 2019
  • BSIG 2014
  • Fundamental
  • Price
  • VIR $7.27
  • BSIG $26.34
  • Analyst Decision
  • VIR Buy
  • BSIG Sell
  • Analyst Count
  • VIR 5
  • BSIG 2
  • Target Price
  • VIR $36.40
  • BSIG $29.00
  • AVG Volume (30 Days)
  • VIR 1.2M
  • BSIG 231.9K
  • Earning Date
  • VIR 02-20-2025
  • BSIG 01-30-2025
  • Dividend Yield
  • VIR N/A
  • BSIG 0.15%
  • EPS Growth
  • VIR N/A
  • BSIG N/A
  • EPS
  • VIR N/A
  • BSIG 1.65
  • Revenue
  • VIR $78,618,000.00
  • BSIG $469,000,000.00
  • Revenue This Year
  • VIR N/A
  • BSIG $15.57
  • Revenue Next Year
  • VIR N/A
  • BSIG $8.49
  • P/E Ratio
  • VIR N/A
  • BSIG $15.93
  • Revenue Growth
  • VIR N/A
  • BSIG 12.17
  • 52 Week Low
  • VIR $6.56
  • BSIG $18.09
  • 52 Week High
  • VIR $13.09
  • BSIG $31.52
  • Technical
  • Relative Strength Index (RSI)
  • VIR 42.92
  • BSIG 27.91
  • Support Level
  • VIR $7.22
  • BSIG $26.52
  • Resistance Level
  • VIR $7.64
  • BSIG $27.49
  • Average True Range (ATR)
  • VIR 0.35
  • BSIG 0.80
  • MACD
  • VIR -0.01
  • BSIG -0.42
  • Stochastic Oscillator
  • VIR 30.43
  • BSIG 5.35

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About BSIG BrightSphere Investment Group Inc.

BrightSphere Investment Group Inc is a diversified, multi-boutique asset management company. The company's diverse affiliates offer alpha-generating investment products to investors around the world. Its reportable segment includes Quant and Solutions, which comprises versatile, tailored strategies that leverage data and technology in a computational, factor-based investment process across a range of asset classes in developed and emerging markets, including non-U.S. and small-cap equities, as well as managed volatility, ESG, multi-asset, equity alternatives, and long/short strategies. Its affiliates offer products in the U.S, international and emerging markets equities; U.S. fixed income; and alternative investments, including timber and secondary Funds.

Share on Social Networks: